Inflammatory eye diseases2019-02-01T11:45:22+00:00

GreenLight Pharma icons-04

GreenLight Medicines researchers are working on a range of inflammatory eye diseases to improve the quality of patients’ lives.

Cannabinoids have been proven to greatly reduce inflammation.

Our unique delivery method, which transports molecules, helps to deliver our proprietary cannabinoid blends efficiently into the eye to gain maximum localised results.

Sign Up For Clinical Trials